Long Term Follow-up Hybrid Revascularization

Completed

• Conditions: Coronary Artery Disease
• Interventions: Procedure: Robotic Hybrid coronary artery revascularization

• Registration Number: NCT01955330
• Lead Sponsor: Lawson Health Research Institute

Brief Summary

OBJECTIVES:

The objectives of the year study are two-fold:

1. To determine the 5-7 year patency rate (rate of open bypass grafts) of the LITA graft and stent of patients who have already had robotically-assisted Hybrid CABG surgery using CTA and MPS-MIBI.

2. To determine patient quality of life at 5-7 years after robotically-assisted Hybrid CABG surgery

Detailed Description

New techniques such as robotically-assisted Hybrid CABG surgery need proper evaluation to ensure potential benefits gained are not harmful to that which we know to be of significant benefit to the patients, that being the left internal thoracic artery (LITA) graft (one of the main coronary arteries supplying your heart with blood). We are therefore proposing a 5-7 year CT-Angiography (CTA) and Myocardial Perfusion Scintigraphy (MPS-MIBI) to assess the patency rate of the LITA graft and the stented graft in patients that have already undergone robotically assisted Hybrid CABG.

Study Timeline

• Study Start: 2013-09
• Study First Submitted: 2013-09-27
• Study First Submitted QC: 2013-09-27
• Study First Posted: 2013-10-07
• Primary Completion: 2017-09
• Study Completion: 2018-09
• Status Verified: 2018-11
• Last Update Submitted: 2018-11-02
• Last Update Posted: 2018-11-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Patients that have previously had Hybrid robotic coronary artery revascularization performed approximately 5-7 years ago at the London Health Sciences Centre, University Hospital by Dr. Kiaii.

Exclusion Criteria

• Patients not described above

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Hybrid robotic cabg patients	Robotic Hybrid coronary artery revascularization	Postoperative (5-7 years)Hybrid CABG robotically assisted surgical revascularization patients

Primary Outcome Measures

Name	Time	Method
Graft patency	5-7 years post Hybrid surgery	To assess the graft patency of the LITA to LAD performed by the robot and the patency of the Stent.

Trial Locations

Locations (1)

London Health Sciences Centre, University & Victoria Hospitals; 🇨🇦 London, Ontario, Canada